Beyond the lab: PhDIBINEM - Unibo

This episode examines the EU’s AI Act, the transformative role of telemedicine, and the critical challenges of safeguarding patient data. We explore the legal compliance landscape, offering insights into the intersection of technology, ethics, and law...

This episode examines the EU’s AI Act, the transformative role of telemedicine, and the critical challenges of safeguarding patient data. We explore the legal compliance landscape, offering insights into the intersection of technology, ethics, and law in healthcare innovation

The intersection of neuroscience and technology offers transformative opportunities for addressing sensorimotor impairments, with advances in brain-machine interfaces, virtual reality, neurofeedback, and alternate neural pathway research driving...

The intersection of neuroscience and technology offers transformative opportunities for addressing sensorimotor impairments, with advances in brain-machine interfaces, virtual reality, neurofeedback, and alternate neural pathway research driving innovations in assistive technologies that restore movement, enhance independence, and improve quality of life.

The integration of advanced radiological techniques, such as radiomics, quantitative CT, and advanced MRI sequences, represents a transformative approach in the study of biology and neuromotor sciences, offering new perspectives in radiological...

The integration of advanced radiological techniques, such as radiomics, quantitative CT, and advanced MRI sequences, represents a transformative approach in the study of biology and neuromotor sciences, offering new perspectives in radiological imaging and clinical practice.

New markers in precision hematology: circulating tumor cells and cell-free DNA as peripheral markers of hematological disease, new markers in flow cytometry to differentiate aberrant cells from normal ones and to study the tumor microenvironment,...

New markers in precision hematology: circulating tumor cells and cell-free DNA as peripheral markers of hematological disease, new markers in flow cytometry to differentiate aberrant cells from normal ones and to study the tumor microenvironment, extracellular vesicles as risk markers for the disease.

Therapeutic resistance and the risks of progression remain an ongoing challenge for various hematological malignancies, including acute promyelocytic leukemia, chronic myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.  

Therapeutic resistance and the risks of progression remain an ongoing challenge for various hematological malignancies, including acute promyelocytic leukemia, chronic myeloproliferative neoplasms, myelodysplastic syndromes, and acute myeloid leukemia.